Know Cancer

or
forgot password

CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)


N/A
N/A
N/A
Open (Enrolling)
Both
Sarcoma

Thank you

Trial Information

CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)


OBJECTIVES:

- To demonstrate CRKL expression at the protein level in rhabdomyosarcoma tumors by
tissue microarray (TMA).

OUTLINE: Archived tumor tissue samples are analyzed for CRKL expression.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma specimens from the Children
Oncology Group (COG) tumor microarrays (TMAs)

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

CRKL expression at the protein level

Safety Issue:

No

Principal Investigator

Lee J. Helman, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)

Authority:

United States: Federal Government

Study ID:

CDR0000719965

NCT ID:

NCT01496573

Start Date:

December 2011

Completion Date:

Related Keywords:

  • Sarcoma
  • alveolar childhood rhabdomyosarcoma
  • embryonal childhood rhabdomyosarcoma
  • childhood rhabdomyosarcoma
  • Rhabdomyosarcoma
  • Sarcoma

Name

Location